- Home
- IVDA vs ENVB Comparison
IVDA vs ENVB Comparison
Compare IVDA & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | ENVB |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.0M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | IVDA | ENVB |
|---|---|---|
| Price | $0.27 | $1.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 623.3K | 22.3K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,914,675.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.22 | $0.56 |
| 52 Week High | $3.13 | $13.25 |
Technical Indicators
Market Signals| Indicator | IVDA | ENVB |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 44.41 |
| Support Level | $0.23 | $1.81 |
| Resistance Level | $0.28 | $2.06 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 55.71 | 44.44 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.